loader image
Saturday, December 20, 2025
62.6 F
McAllen
- Advertisement -

NAH students join with communities against COVID-19

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

MCALLEN, TEXAS– Vocational Nursing students from STC’s Nursing and Allied Health Campus have stepped up to assist communities in the Rio Grande Valley as they begin to receive their COVID vaccinations. 

LVN students answered calls for assistance by Edcouch-Elsa ISD and Hidalgo County to begin the pre-screening process as that community begins to vaccinate the elderly in response to the pandemic. They began with the pre-screening of citizens 65 years or older on Feb. 2 ahead of the vaccination event taking place on Feb. 3.

After the pre-screening, the COVID-19 vaccines are then administered by healthcare professionals including doctors, nurses, pharmacists, physicians assistants, and pharmacy technicians who have received training on how to administer the vaccine and how to manage very rare side effects of the vaccines. 

- Advertisement -

“This is who we are,” said STC NAH Dean Dr. Jayson Valerio. “As NAH students and faculty at South Texas College, our main mission is to meet the healthcare needs of our growing and diverse community, and right now they need our help.”  

Along with LVN students, Valerio said he has been urging NAH students from its LVN program, Associate Degree Nursing (ADN) program as well as its new Bachelor of Science in Nursing (BSN) since the fall to be prepared for assisting local communities. 

Students assisted with vaccinations in Edcouch-Elsa on Feb. 3, and plan to assist in Donna and then Starr County in the coming weeks.

“I told them before the fall semester ended to be ready because at any moment we anticipate that they will need our help to administer the COVID-19 vaccines,” Valerio said. “I want to instill in our students the social responsibility and civic responsibility because they are our future healthcare leaders.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×